Rein, L. A. M., Chen, M., Theriot, B. S., Wisler, J. W., Wingler, L. M., Premont, R. T., … Lefkowitz, R. J. (2013). Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia. In Blood (Vol. 122, pp. 857–857). American Society of Hematology. https://doi.org/10.1182/blood.v122.21.857.857

Rein, Lindsay A. M., Minyong Chen, Barbara S. Theriot, James W. Wisler, Laura M. Wingler, Richard T. Premont, Wei Chen, Julia K. L. Walker, and Robert J. Lefkowitz. “Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia.” In Blood, 122:857–857. American Society of Hematology, 2013. https://doi.org/10.1182/blood.v122.21.857.857.

Rein LAM, Chen M, Theriot BS, Wisler JW, Wingler LM, Premont RT, et al. Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia. In: Blood. American Society of Hematology; 2013. p. 857–857.

Rein, Lindsay A. M., et al. “Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia.” Blood, vol. 122, no. 21, American Society of Hematology, 2013, pp. 857–857. Crossref, doi:10.1182/blood.v122.21.857.857.

Rein LAM, Chen M, Theriot BS, Wisler JW, Wingler LM, Premont RT, Chen W, Walker JKL, Lefkowitz RJ. Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia. Blood. American Society of Hematology; 2013. p. 857–857.